No Serious CV Risks for Elderly After Pfizer COVID-19 Vaccine No Serious CV Risks for Elderly After Pfizer COVID-19 Vaccine
A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events in elderly individuals.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news
More News: Cardiology | Cardiovascular | COVID-19 | France Health | Heart | Pfizer | Study | Vaccines